MYFORTIC

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug MYFORTIC contains one active pharmaceutical ingredient (API):

1	Mycophenolic acid UNII WX877SQI1G - MYCOPHENOLATE SODIUM
	Mycophenolic acid is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Mycophenolic acid has more potent cytostatic effects on lymphocytes than on other cells and is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.
	Read more about Mycophenolic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYFORTIC Gastro-resistant tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AA06	Mycophenolic acid	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2150E, 2193K, 6369F, 6370G, 9503E, 9504F
BR	Câmara de Regulação do Mercado de Medicamentos	526511001113213, 526511002111214
CA	Health Products and Food Branch	02264560, 02264579
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00080051, 00081197, 00361057, 00361063, 00361086, 00445771, 01755321, 01755338, 01755396, 01755404, 02251858, 05395919, 05481091, 06733086, 06733092, 06733100, 06735010, 06735027, 06735033, 06799286, 08446534, 08446563, 08446586, 09264290, 09264309, 10738304, 10738310, 10738327, 10813460, 10813477, 11369895, 11369903, 11645817, 11645823, 12500392, 15612387, 15877878, 16701503, 16811953, 16812361, 17448124, 17562831, 17562848, 17845693
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.142-05-03, 25.143-05-03, 4623-MEE-0319, 4626-MEE-0319
EE	Ravimiamet	1164619, 1164620, 1164631, 1164642, 1164653, 1164675, 1164686, 1164697, 1738043
ES	Centro de información online de medicamentos de la AEMPS	66140, 66141
FI	Lääkealan turvallisuus- ja kehittämiskeskus	015722, 015744
FR	Base de données publique des médicaments	67858369, 69678277
GB	Medicines & Healthcare Products Regulatory Agency	80776, 80779
HK	Department of Health Drug Office	51396, 51397, 65402, 65403
HR	Agencija za lijekove i medicinske proizvode	HR-H-505070647, HR-H-950094160
IE	Health Products Regulatory Authority	88719, 88725
IL	מִשְׂרַד הַבְּרִיאוּת	4698, 4699
IT	Agenzia del Farmaco	036511032, 036511069
LT	Valstybinė vaistų kontrolės tarnyba	1004964, 1017717, 1017718, 1017719, 1017720, 1017721, 1017723, 1017724, 1021384, 1070336
MT	Medicines Authority	MA1249/00301, MA1249/00302, PI565/78501A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	070M2003
NG	Registered Drug Product Database	A4-4289
Switch country to Nigeria in order to find specific presentations of MYFORTIC
NL	Z-Index G-Standaard, PRK	74942, 74950
NZ	Medicines and Medical Devices Safety Authority	10595, 10596
PL	Rejestru Produktów Leczniczych	100136417, 100136742
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W42264001, W42264002, W42264003, W42264004, W42265001, W42265002, W42265003, W42265004
SG	Health Sciences Authority	12376P, 12377P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504040050, 8699504040104
US	FDA, National Drug Code	0078-0385, 0078-0386
ZA	Health Products Regulatory Authority	37/34/0158, 37/34/0159